1.4 A PROTEOMIC MARKER OF DIABETIC NEPHROPATHY IS ASSOCIATED WITH MORTALITY IN PATIENTS WITH TYPE 2 DIABETES
Background: The urinary proteomic classifier CKD273 has been found to predict diabetic nephropathy development in advance of microalbuminuria. Whether it is also a determinant of mortality and cardiovascular disease in patients with established albuminuria is unknown. Methods: We studied 155 subjec...
Main Authors: | Gemma Currie, Sheon Mary, Bernt Johan von Scholten, Morten Kofod Lindhardt, Harald Mischak, William Mullen, Peter Rossing, Christian Delles |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-12-01
|
Series: | Artery Research |
Online Access: | https://www.atlantis-press.com/article/125930184/view |
Similar Items
-
P3.3 THE CKD273 URINARY PROTEOMIC BIOMARKER FOR EARLY DIAGNOSIS OF DIABETIC NEPHROPATHY DOES NOT INDICATE GENERALISED SUBCLINICAL VASCULAR DISEASE IN NORMOALBUMINURIC TYPE 2 DIABETIC PATIENTS
by: Gemma Currie*, et al.
Published: (2015-11-01) -
Urinary proteomics for prediction of mortality in patients with type 2 diabetes and microalbuminuria
by: Gemma E. Currie, et al.
Published: (2018-04-01) -
Multicentric validation of proteomic biomarkers in urine specific for diabetic nephropathy.
by: Alaa Alkhalaf, et al.
Published: (2010-01-01) -
P3.5 URINARY PROTEOMICS AND VASCULAR PHENOTYPING IN A COHORT OF TYPE 2 DIABETIC PATIENTS AT HIGH CARDIOVASCULAR RISK
by: G. Currie, et al.
Published: (2014-11-01) -
Plasma proteome analysis of patients with type 1 diabetes with diabetic nephropathy
by: Rossing Peter, et al.
Published: (2010-02-01)